DevicePMAs@therightstef:P100022_S020 / 93-101 JSONTXT

Approval for the Zilver PTX Drug-Eluting Peripheral Stent is indicated for improving luminal diameter for the treatment of de novo or restenotic symptomatic lesions in native vascular disease of the above-the-knee femoropopliteal arteries having reference vessel diameter from 4 mm to 7 mm and total lesion lengths up to 300 mm per patient.

projects that have annotations to this span

Unselected / annnotation Selected / annnotation
PMA_MER 1 (1)